Setyo G. Pramudo
Semarang, JT, Indonesia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.
Journal: Human vaccines & immunotherapeutics
Published: May 17, 2025
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.
Journal: Human vaccines & immunotherapeutics
Published: December 05, 2024
Characteristics, attitudes, and the odds for positive attitude toward clinical trial: A study on Indonesian COVID-19 vaccine trial participants.
Journal: Perspectives in clinical research
Published: March 14, 2023
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients.
Journal: Thrombosis and haemostasis
Published: October 11, 2022
Longitudinal proteomic profiling of the inflammatory response in dengue patients.
Journal: PLoS neglected tropical diseases
Published: April 26, 2022
Determinant Factors of COVID-19 Vaccine Hesitancy Among Adult and Elderly Population in Central Java, Indonesia.
Journal: Patient preference and adherence
Published: March 11, 2022
Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma Leakage.
Journal: Frontiers in immunology
Published: August 16, 2021
Effect of oseltamivir phosphate versus placebo on platelet recovery and plasma leakage in adults with dengue and thrombocytopenia; a phase 2, multicenter, double-blind, randomized trial.
Journal: PLoS neglected tropical diseases
Published: July 02, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026